{'fraction_non_alphanumeric': 0.024390243902439025, 'fraction_numerical': 0.0, 'mean_word_length': 5.737704918032787, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Research consortium offers new hope for Parkinson's disease

Until recently, research progress in the field of Parkinson's disease has been slow compared with other therapeutic areas. However, a new consortium of pharmaceutical companies, academic researchers and charities – the Critical Path for Parkinson's Consortium – is helping to accelerate the development of new treatments to slow disease progression.